NFKBIA and asthma: Our study indicates that MaR1 plays an anti-inflammatory role in OVA-induced asthma inflammation by suppressing the degradation of IκBα and the NF-κB signaling pathway, strongly suggesting that MaR1 may be used as a potential drug for the treatment of asthma in the future.